GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.500
-0.065 (-2.53%)
Mar 9, 2026, 4:00 PM EDT - Market closed
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.61 million as of March 9, 2026. Its market cap has decreased by -7.08% in one year.
Market Cap
3.61M
Enterprise Value
-4.55M
1-Year Change
-7.08%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.61M, a decrease of -85.71%. That is a compound annual growth rate of -49.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.71M | 48.39% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 4.52M |
| Silo Pharma | 4.36M |
| Galmed Pharmaceuticals | 4.34M |
| Indaptus Therapeutics | 4.15M |
| Decoy Therapeutics | 4.03M |
| Matinas BioPharma Holdings | 3.85M |
| Oragenics | 3.84M |
| HCW Biologics | 3.57M |